FTC's Take On Drug Sales To Rivals May Cost Pharma
The Federal Trade Commission on Monday urged a New Jersey court to keep alive a case accusing Actelion Pharmaceutical Ltd. of breaching antitrust laws by refusing to supply generic rivals with...To view the full article, register now.
Already a subscriber? Click here to view full article